Estrella Immunopharma, Inc. – NASDAQ:ESLA
Estrella Immunopharma stock price today
Estrella Immunopharma stock price monthly change
Estrella Immunopharma stock price quarterly change
Estrella Immunopharma stock price yearly change
Estrella Immunopharma key metrics
Market Cap | 39.07M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -1.85 |
Revenue | N/A |
EBITDA | -3.52M |
Income | -3.43M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeEstrella Immunopharma stock price history
Estrella Immunopharma stock forecast
Estrella Immunopharma financial statements
| Jun 2023 | 0 | -76.00K | |
|---|---|---|---|
| Sep 2023 | 0 | -1.87M | |
| Dec 2023 | 0 | -1.02M | |
| Mar 2024 | 0 | -469.53K |
| Dec 2022 | 3054289 | 9.53M | 312.02% |
|---|---|---|---|
| Sep 2023 | 27349707 | 17.28M | 63.18% |
| Dec 2023 | 9447263 | 398.73K | 4.22% |
| Mar 2024 | 8633400 | 138.49K | 1.6% |
| Jun 2023 | -212.66K | 21.43K | 196.53K |
|---|---|---|---|
| Sep 2023 | -275.19K | -112.29K | 20.04M |
| Dec 2023 | -11.26M | 5.07M | -6.89M |
| Mar 2024 | -4.23M | 0 | -84.09K |
Estrella Immunopharma other data
-
What's the price of Estrella Immunopharma stock today?
One share of Estrella Immunopharma stock can currently be purchased for approximately $0.92.
-
When is Estrella Immunopharma's next earnings date?
Unfortunately, Estrella Immunopharma's (ESLA) next earnings date is currently unknown.
-
Does Estrella Immunopharma pay dividends?
No, Estrella Immunopharma does not pay dividends.
-
How much money does Estrella Immunopharma make?
Estrella Immunopharma has a market capitalization of 39.07M.
-
What is Estrella Immunopharma's stock symbol?
Estrella Immunopharma, Inc. is traded on the NASDAQ under the ticker symbol "ESLA".
-
What is Estrella Immunopharma's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Estrella Immunopharma?
Shares of Estrella Immunopharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When Estrella Immunopharma went public?
Estrella Immunopharma, Inc. is publicly traded company for more then 4 years since IPO on 14 Sep 2021.
-
What is Estrella Immunopharma's official website?
The official website for Estrella Immunopharma is estrellabio.com.
-
Where are Estrella Immunopharma's headquarters?
Estrella Immunopharma is headquartered at 5858 Horton Street, EmeryVille, CA.
-
How can i contact Estrella Immunopharma?
Estrella Immunopharma's mailing address is 5858 Horton Street, EmeryVille, CA and company can be reached via phone at +51 03189098.
Estrella Immunopharma company profile:
Estrella Immunopharma, Inc.
estrellabio.comNASDAQ
0
Biotechnology
Healthcare
Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103 for the treatment of diffuse large B-cell lymphoma and is in pre clinical trial; and EB104 to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia. It has a collaborative partnership with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. is based in EmeryVille, California.
EmeryVille, CA 94608
CIK: 0001844417
ISIN: US2975841048
:
